Breast cancer and combined oral contraceptives: Results from the Collaborative Group on Hormonal Factors in Breast Cancer

Breast cancer and combined oral contraceptives: Results from the Collaborative Group on Hormonal Factors in Breast Cancer

Bibliografski detalji
Glavni autori:	Beral, V, Reeves, G
Format:	Conference item
Izdano:	1998

Slični predmeti

Breast cancer and hormonal contraceptives: further results. Collaborative Group on Hormonal Factors in Breast Cancer.
od: Beral, V
Izdano: (1996)

Childbearing, oral contraceptive use, and breast cancer.
od: Beral, V, i dr.
Izdano: (1993)

CHILDBEARING, ORAL-CONTRACEPTIVE USE, AND BREAST-CANCER
od: Beral, V, i dr.
Izdano: (1993)

Breast cancer and hormone replacement therapy: collaborative reanalysis of data from 51 epidemiological studies of 52,705 women with breast cancer and 108,411 women without breast cancer. Collaborative Group on Hormonal Factors in Breast Cancer.
od: Beral, V
Izdano: (1997)

Breast cancer and hormonal contraceptives: Further results
od: Calle, E, i dr.
Izdano: (1996)

Breast cancer trends in women in Sweden, the UK, and the USA in relation to their past use of oral contraceptives
od: Beral, V, i dr.
Izdano: (1996)

Combined and progestagen-only hormonal contraceptives and breast cancer risk: a UK nested case–control study and meta-analysis
od: Fitzpatrick, D, i dr.
Izdano: (2023)

Breast cancer and oral contraceptives--the evidence so far.
od: Reeves, G
Izdano: (1996)

Breast cancer and hormonal contraceptives: collaborative reanalysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Collaborative Group on Hormonal Factors in Breast Cancer.
od: Cancer, C
Izdano: (1996)

Breast Cancer Risk in Relation to Use of Combined and Progestogen-Only Contraceptives: Results from a UK Record-Linkage Study
od: Reeves, G, i dr.
Izdano: (2012)

Hormone Therapy, Breast Cancer Risk and the Collaborative Group on Hormonal Factors in Breast Cancer Article
od: Luciano de Melo Pompei, i dr.
Izdano: (2020-06-01)

Breast cancer and hormone exposure - Reply
od: Beral, V, i dr.
Izdano: (1996)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct.
od: Banks, E, i dr.
Izdano: (2004)

Combined and progestagen-only hormonal contraceptives and breast cancer risk: A UK nested case-control study and meta-analysis.
od: Danielle Fitzpatrick, i dr.
Izdano: (2023-03-01)

Meta-analysis: Use of combined oral contraceptives in the past 10 years is associated with an increased risk for breast cancer
od: Beral, V
Izdano: (1996)

Oral contraceptives and menopausal hormone therapy as breast cancer risk categories
od: I. V. Vуsotskaya, i dr.
Izdano: (2019-09-01)

Oral contraceptives and breast cancer.
od: McPherson, K, i dr.
Izdano: (1983)

Published results on breast cancer and hormone replacement therapy in the Million Women Study are correct (multiple letters)
od: Banks, E, i dr.
Izdano: (2004)

Menopausal hormone therapy and 20-year breast cancer mortality
od: Beral, V, i dr.
Izdano: (2019)

AGE-SPECIFIC DIFFERENCES IN THE RELATION BETWEEN ORAL-CONTRACEPTIVE USE AND BREAST-CANCER
od: Wingo, P, i dr.
Izdano: (1990)

Age-specific differences in the relationship between oral contraceptive use and breast cancer.
od: Wingo, P, i dr.
Izdano: (1993)

Age-specific differences in the relationship between oral contraceptive use and breast cancer.
od: Wingo, P, i dr.
Izdano: (1991)

Hormone replacement therapy and high incidence of breast cancer between mammographic screens.
od: Beral, V, i dr.
Izdano: (1997)

Breast cancer risk in relation to the interval between menopause and starting hormone therapy.
od: Beral, V, i dr.
Izdano: (2011)

Breast cancer and hormonal contraceptives: Collaborative reanalysis of individual data on 53297 women with breast cancer and 100239 women without breast cancer from 54 epidemiological studies
od: Calle, E, i dr.
Izdano: (1996)

Impact of hormone replacement therapy on breast cancer
od: Gathani, T, i dr.
Izdano: (2010)

Breast cancer and hormone-replacement therapy: the Million Women Study - Reply
od: Beral, V, i dr.
Izdano: (2003)

Variations in the Prevalence of Risk Factors for Breast Cancer in Different Ethnic Groups in the Million Women Study
od: Gathani, T, i dr.
Izdano: (2012)

Ovarian cancer and oral contraceptives: collaborative reanalysis of data from 45 epidemiological studies including 23,257 women with ovarian cancer and 87,303 controls.
od: Beral, V, i dr.
Izdano: (2008)

Breast cancer and hormone-replacement therapy in the Million Women Study.
od: Beral, V
Izdano: (2003)

Breast cancer and abortion: collaborative reanalysis of data from 53 epidemiological studies, including 83?000 women with breast cancer from 16 countries.
od: Beral, V, i dr.
Izdano: (2004)

Hormone replacement therapy increase breast cancer incidence and may increase breast cancer mortality in postmenopausal women
od: Beral, V, i dr.
Izdano: (2004)

Oral contraceptives and the small increased risk of breast cancer
od: Hunter, D
Izdano: (2017)

BREAST-CANCER AND THE ESTROGEN CONTENT OF ORAL-CONTRACEPTIVES - REPLY
od: Mcpherson, K, i dr.
Izdano: (1984)

Oral contraceptives and the small increased risk of breast cancer
od: Hunter, D
Izdano: (2017)

Injectable and Oral Contraceptive Use and Cancers of the Breast, Cervix, Ovary, and Endometrium in Black South African Women
od: Urban, M, i dr.
Izdano: (2013)

Early oral contraceptive use and breast cancer: results of another case-control study.
od: McPherson, K, i dr.
Izdano: (1987)

Hormonal therapy for menopause and breast-cancer risk by histological type: a cohort study and meta-analysis.
od: Reeves, G, i dr.
Izdano: (2006)

Oral contraceptives and breast cancer. A prospective cohort study.
od: Lipnick, R, i dr.
Izdano: (1986)

Re-Evaluating the Association Between Hormonal Contraception and Breast Cancer Risk
od: Satish S, i dr.
Izdano: (2023-03-01)